Comparative Effectiveness of Two Doses Versus Three Doses of Hepatitis A Vaccine in Kidney transplant recipients in Chulalongkorn hospital

Phase 4

Recruiting

• Conditions: Allergy; Hepatitis A; Hepatitis A vaccine; Kidney transplant recipients; Prevalence of hepatitis A; Three doses of hepatitis A vaccine

• Registration Number: TCTR20180325001
• Lead Sponsor: Faculty of Medicine Chulalongkorn university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-03-25
• Study Completion: 2018-10-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Kidney transplant recipients who age over 18 year-old in Chulalongkorn hospital

Exclusion Criteria

Kidney transplant recipients who known allergy to hepatitis A vaccine

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparative Effectiveness of 2 Versus 3 Doses of Hepatitis A Vaccine in Kidney transplant recipients 2 years Automated chemiluminescent micro particle immunoassay

Secondary Outcome Measures

Name	Time	Method
Prevalence of seropositive for anti-HAV IgG in Kidney transplant recipients 1 year Automated chemiluminescent micro particle immunoassay